GC-1 Sobetirome
Shop GC-1 Sobetirome on KimeraChems · code GUIDE (10% off)Definition
GC-1 Sobetirome is a thyroid-hormone receptor agonist researched for its preferential activity at thyroid receptor beta. In research contexts, it is primarily explored for its potential to influence lipid metabolism, hepatic gene expression, and energy-expenditure-related endpoints, with the goal of capturing thyroid-like metabolic effects while reducing thyroid receptor alpha-driven effects that are more strongly associated with cardiac stimulation. GC-1 is commonly discussed in metabolic research as a tool compound for studying thyroid-receptor selectivity, cholesterol handling, and fat-loss-related pathways.
Available Formats
- 30 mL liquid solution (200 mcg per mL / 6 mg total)
Mechanism of Action
Research suggests GC-1 Sobetirome may: Because receptor distribution and baseline thyroid status vary by model, observed outcomes may differ substantially across study designs.
- Activate thyroid receptor beta-mediated transcriptional programs
- Increase hepatic LDL-receptor-expression signaling and cholesterol-clearance endpoints
- Alter lipid-synthesis and lipid-oxidation variables in liver-focused paradigms
- Increase metabolic-rate proxies in select models
- Influence thermogenesis-related markers depending on study design
- Alter thyroid-axis feedback markers depending on exposure and duration
Areas of Investigation
GC-1 Sobetirome is commonly studied in
- Dyslipidemia and cholesterol-lowering research models
- Fat-loss and energy-expenditure paradigms
- Nonalcoholic fatty-liver and hepatic-lipid-accumulation studies
- Thyroid-receptor-selectivity comparisons with T3-like agents
- Metabolic-syndrome models in which lipids and insulin sensitivity are measured endpoints
- Endocrine-safety research focused on cardiac markers and thyroid-axis-suppression signals
Safety Profile
Reported observations include
- Stimulation-like effects, including restlessness, anxiety, and sleep disruption in sensitive models
- Increased heart rate and cardiovascular-strain signals at higher exposures
- Heat-intolerance-like effects and increased sweating
- Appetite changes depending on the model and metabolic state
- Thyroid-axis-suppression signals as a conservative monitoring consideration in longer-duration designs
- Potential changes in liver enzymes and thyroid-associated biomarkers depending on study conditions
Interaction Notes
GC-1 Sobetirome is often explored alongside variables that influence metabolic rate and lipid handling
For educational purposes only. Not for human consumption.